Standards; Pharmaceutical/API Drug Impurities/Metabolites; Carbohydrates and Oligosaccharides;
應(yīng)用:
O-?2,?3,?4-?Tri-?O-?acetyl-?β-?D-?xylopyranosyl-?(1→4)?-?O-?2,?3-?di-?O-?acetyl-?β-?D-?xylopyranosyl-?(1→4)?-?O-?2,?3-?di-?O-?acetyl-?β-?D-?xylopyranosyl-?(1→4)?-?O-?2,?3-?di-?O-?acetyl-?β-?D-?xylopyranosyl-?(1→4)?-?O-?2,?3-?di-?O-?acetyl-?β-?D-?xylopyranosyl-?(1→4)?-?D-?xylopyranose Triacetate + O-?2,?3,?4-?tri-?O-?acetyl-?β-?D-?xylopyranosyl-?(1→4)?-?O-?2,?3-?di-?O-?acetyl-?β-?D-?xylopyranosyl-?(1→4)?-?O-?2,?3-?di-?O-?acetyl-?β-?D-?xylopyranosyl-?(1→4)?-?O-?2,?3-?di-?O-?acetyl-?β-?D-?xylopyranosyl-?(1→4)?-D-?xylopyranose Triacetate (Mixture) is a by-product dur